MRS. PATRICIA JEAN LAMP ANP-C
Prescription History 1891968921
Nurse Practitioner - Family in Elgin, IL
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for MRS. PATRICIA JEAN LAMP ANP-C, an active Family specialist practicing in Elgin, IL. Our medical registry currently tracks 4 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 252 documented patient claims. Among these therapy options, the most frequently utilized medication is Anastrozole, which accounts for 160 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other IL PrescribersVs. IL Avg |
|---|---|---|---|
| Anastrozole | 160 | $20.29 | ▲ More than typical |
About Anastrozole: Anastrozole is used to treat breast cancer in women after menopause. Show more ▾ Some breast cancers are made to grow faster by a natural hormone called estrogen. Anastrozole decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers. A nitrile and triazole derivative that acts as a selective nonsteroidal aromatase inhibitor. It is used in the treatment of ESTROGEN NUCLEAR RECEPTOR-positive breast cancer in postmenopausal women. In 2024, this provider wrote 160 Medicare prescriptions for Anastrozole, about 2.1 times the volume of the typical Illinois prescriber of this medication (75.6). Medicare paid an average of $20.29 per fill, versus $17.15 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 467.5 30-Day Fills standardized to 30-day supplies 14,026 Days of Medication total across all patients in 2024 | |||
| Exemestane | 40 | $173.96▼ below IL avg | ▲ More than typical |
About Exemestane: This medication is used to treat certain types of breast cancer (such as hormone-receptor-positive breast cancer) in women after menopause. Show more ▾ Exemestane is also used to help prevent the cancer from returning. Some breast cancers are made to grow faster by a natural hormone called estrogen. Exemestane decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers. Exemestane is usually not used in women of childbearing age. A hormonal antineoplastic agent. In 2024, this provider wrote 40 Medicare prescriptions for Exemestane, about 1.4 times the volume of the typical Illinois prescriber of this medication (29.2). Medicare paid an average of $173.96 per fill, versus $174.13 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IL average for this medication. 68 30-Day Fills standardized to 30-day supplies 1,656 Days of Medication total across all patients in 2024 | |||
| Letrozole | 32 | $18.65▼ below IL avg | ▼ Less than typical |
About Letrozole: This medication is used to treat certain types of breast cancer (such as hormone-receptor-positive breast cancer) in women after menopause. Show more ▾ Letrozole is also used to help prevent the cancer from returning. Some breast cancers are made to grow faster by a natural hormone called estrogen. Letrozole decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers. A triazole and benzonitrile derivative that is a selective non-steroidal aromatase inhibitor, similar to ANASTROZOLE. It is used in the treatment of metastatic or locally advanced breast cancer in postmenopausal women. In 2024, this provider wrote 32 Medicare prescriptions for Letrozole, about half the volume of the typical Illinois prescriber of this medication (55.6). Medicare paid an average of $18.65 per fill, versus $19.02 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IL average for this medication. 74 30-Day Fills standardized to 30-day supplies 2,215 Days of Medication total across all patients in 2024 | |||
| Tamoxifen Citrate | 20 | $13.17▼ below IL avg | ▼ Less than typical |
About Tamoxifen Citrate: Tamoxifen is used to treat breast cancer. Show more ▾ It is also used to reduce the chances of breast cancer in high-risk patients. This medication can block the growth of breast cancer. It works by interfering with the effects of estrogen in the breast tissue. One of the SELECTIVE ESTROGEN RECEPTOR MODULATORS with tissue-specific activities. Tamoxifen acts as an anti-estrogen (inhibiting agent) in the mammary tissue, but as an estrogen (stimulating agent) in cholesterol metabolism, bone density, and cell proliferation in the ENDOMETRIUM. In 2024, this provider wrote 20 Medicare prescriptions for Tamoxifen Citrate, about half the volume of the typical Illinois prescriber of this medication (35). Medicare paid an average of $13.17 per fill, versus $23.49 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IL average for this medication. 20 30-Day Fills standardized to 30-day supplies 600 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for MRS. PATRICIA JEAN LAMP ANP-C is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Family prescribing approach at this Elgin, IL practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among IL prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
